AGTR2 and Stroke: Since a mild/moderate reduction in BP was also associated with reduction in stroke recurrence and since numerous non-BP lowering effects of ACE inhibition may translate into antithrombotic/fibrinolytic and plaque stabilizing properties, besides actively enhancing the collateral circulation through increased AT2 receptors, there is adequate scientific basis to test these drugs as agents modifying stroke outcomes.